It is the structured set of nutritional and behavioural supports that make the weight lost on GLP-1 the weight that stays off
therefore if transit time is less than 14 hours the patient will have hematochezia, and if greater than 14 hours the patient will exhibit melena
This guide covers why the combination is used, who benefits, dosing, what to expect at each stage of treatment, and how it stacks up against semaglutide alone or other GLP-1 medications
By combining these two well-studied peptides, the product offers targeted support intended to complement recovery, tissue resilience, and overall performance protocols
This effect is believed to be due to IGF-1 suppression of insulin secretion, which leads to augmented lipolysis in adipose tissue and promotion of FFA use by muscle